-
Mylan, Atomo Announce WHO Prequalification Approval for HIV Self Test
americanpharmaceuticalreview
July 09, 2019
Mylan and medical device manufacturer Atomo Diagnostics announced the Mylan HIV Self Test, a handheld in vitro HIV rapid diagnostic test for self-testing, has received Prequalification approval by the World Health Organization (WHO PQ).
-
Global diabetes drug market expected to rise 3.6 percent
europeanpharmaceuticalreview
June 26, 2019
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
-
WHO: Congo Ebola Outbreak Still Not Global Emergency
drugs
June 18, 2019
WHO: Congo Ebola Outbreak Still Not Global Emergency.
-
WHO announces support for drug pricing transparency
drugs
June 03, 2019
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
-
WHO adopts resolution on drug pricing transparency
pharmaceutical-technology
May 31, 2019
Member countries of the World Health Organization (WHO) have agreed to support pricing transparency for medicines, vaccines and other health products.
-
Transgender No Longer Classified as Mental Health Disorder by WHO
drugs
May 30, 2019
Transgender people will no longer be classified as having a mental disorder by the World Health Organization.
-
Work Burnout, Gaming Addiction Classified as Diseases by WHO
drugs
May 29, 2019
Work Burnout, Gaming Addiction Classified as Diseases by WHO.
-
U.S. Lawmakers Say WHO Opioid Guidelines Too Lax
drugs
May 24, 2019
U.S. Lawmakers Say WHO Opioid Guidelines Too Lax.
-
Healthy Lifestyle Recommended for Reducing Dementia Risk
drugs
May 16, 2019
Healthy Lifestyle Recommended for Reducing Dementia Risk.
-
As Merck Ebola vaccine runs short in Congo, WHO looks to J&J experimental drug
fiercepharma
May 12, 2019
With an Ebola outbreak in Congo outrunning vaccination efforts to control it and the supplies of Merck’s Ebola vaccine on hand, the World Health Organization has revamped its plan of attack.